Diabetic Complications and Economic Fundamentals
CFO News Room
NOVEMBER 12, 2022
The legislation aims to lower the cost of insulin, a life-prolonging medication for many diabetics, by investing $100 million, half designated for developing a biosimilar insulin and half for producing it. Per usual, economic principles suggest a vastly different outcome than optimistic policy makers. Diabetics Face Tradeoffs Too.
Let's personalize your content